• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阴道环持续释放低剂量雌二醇与雌三醇阴道乳膏治疗泌尿生殖道萎缩的比较

Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.

作者信息

Barentsen R, van de Weijer P H, Schram J H

机构信息

Department of Obstetrics and Gynecology, Elkerliek Hospital, Helmond, The Netherlands.

出版信息

Eur J Obstet Gynecol Reprod Biol. 1997 Jan;71(1):73-80. doi: 10.1016/s0301-2115(96)02612-7.

DOI:10.1016/s0301-2115(96)02612-7
PMID:9031963
Abstract

OBJECTIVES

To determine if the efficacy of continuous low dose estradiol released from a vaginal ring is equivalent to estriol vaginal cream regarding improvement of the patient's subjective feeling of vaginal dryness and to determine if there is a preference for either of the two study treatments.

METHODS

Open-label randomized parallel group trial with active control with a blind evaluation of vaginal cytology and with a cross-over (change-over) phase for preference comparison. One hundred and sixty five postmenopausal women with symptoms of vaginal dryness and signs of vaginal atrophy were randomized to an estradiol ring (Estring) or estriol cream (Synapause). The duration of each treatment period was 12 weeks.

RESULTS

Both study treatments were equally effective regarding the ability to alleviate the symptom feeling of vaginal dryness and the signs of vaginal atrophy. Both treatments were efficient in restoring the vaginal mucosa, recorded as higher maturation values and as decreased vaginal pH. Estring was superior to estriol cream regarding preference of treatment. Both treatments were equivalent for the occurrence of adverse events, including bleeding.

CONCLUSION

data from this change-over study confirm efficacy and safety of both the vaginal ring and cream in the treatment of postmenopausal women with urogenital atrophy symptoms and signs. The patients had a strong preference for the vaginal ring.

摘要

目的

确定阴道环释放的持续低剂量雌二醇在改善患者阴道干燥主观感受方面的疗效是否等同于雌三醇阴道乳膏,并确定患者对两种研究治疗方法是否存在偏好。

方法

开放标签随机平行组试验,采用活性对照,对阴道细胞学进行盲法评估,并设有交叉(转换)阶段用于偏好比较。165名有阴道干燥症状和阴道萎缩体征的绝经后女性被随机分为接受雌二醇环(爱斯妥)或雌三醇乳膏(司诺美孚)治疗。每个治疗期持续12周。

结果

两种研究治疗方法在缓解阴道干燥症状和阴道萎缩体征方面同样有效。两种治疗方法在恢复阴道黏膜方面均有效,表现为成熟值升高和阴道pH值降低。在治疗偏好方面,爱斯妥优于雌三醇乳膏。两种治疗方法在不良事件(包括出血)的发生方面相当。

结论

这项交叉研究的数据证实了阴道环和乳膏在治疗有泌尿生殖萎缩症状和体征的绝经后女性方面的疗效和安全性。患者对阴道环有强烈偏好。

相似文献

1
Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.阴道环持续释放低剂量雌二醇与雌三醇阴道乳膏治疗泌尿生殖道萎缩的比较
Eur J Obstet Gynecol Reprod Biol. 1997 Jan;71(1):73-80. doi: 10.1016/s0301-2115(96)02612-7.
2
A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.一项关于新型阴道环释放的持续低剂量雌二醇与雌三醇阴道栓剂对有泌尿生殖系统萎缩症状和体征的绝经后妇女影响的多中心比较研究。
Am J Obstet Gynecol. 1994 Sep;171(3):624-32. doi: 10.1016/0002-9378(94)90074-4.
3
A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.阴道环释放的持续低剂量雌二醇与结合马雌激素阴道乳膏治疗绝经后泌尿生殖系统萎缩的安全性和有效性比较研究。
Br J Obstet Gynaecol. 1996 Apr;103(4):351-8. doi: 10.1111/j.1471-0528.1996.tb09741.x.
4
A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.一项评价雌二醇阴道乳膏 0.003%用于绝经后以阴道干燥为最困扰症状的女性的安全性和有效性的随机、多中心、双盲研究。
J Womens Health (Larchmt). 2018 Mar;27(3):231-237. doi: 10.1089/jwh.2017.6515. Epub 2017 Dec 1.
5
Evaluation of the efficacy and safety of hyaluronic acid vaginal gel to ease vaginal dryness: a multicenter, randomized, controlled, open-label, parallel-group, clinical trial.评估透明质酸阴道凝胶缓解阴道干燥的疗效和安全性:一项多中心、随机、对照、开放性、平行分组、临床试验。
J Sex Med. 2013 Jun;10(6):1575-84. doi: 10.1111/jsm.12125. Epub 2013 Apr 9.
6
A one-year multicenter study of efficacy and safety of a continuous, low-dose, estradiol-releasing vaginal ring (Estring) in postmenopausal women with symptoms and signs of urogenital aging.一项针对有泌尿生殖系统老化症状和体征的绝经后女性,使用持续低剂量释放雌二醇阴道环(Estring)的疗效和安全性的为期一年的多中心研究。
Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):85-92. doi: 10.1016/s0002-9378(96)70378-2.
7
The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study.一种新的超低浓度雌三醇凝胶制剂(0.005%雌三醇阴道凝胶)治疗绝经后阴道萎缩症状和体征的疗效:一项关键的 III 期研究结果。
Menopause. 2012 Oct;19(10):1130-9. doi: 10.1097/gme.0b013e3182518e9a.
8
Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?阴道透明质酸对于缓解阴道干燥与阴道用雌三醇同样有效吗?
Arch Gynecol Obstet. 2013 Dec;288(6):1199-201. doi: 10.1007/s00404-013-3068-5.
9
Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.乳腺癌幸存者中应用低剂量阴道雌激素或阴道润滑剂治疗泌尿生殖系统萎缩:一项初步研究。
Gynecol Endocrinol. 2010 Jun;26(6):404-12. doi: 10.3109/09513591003632258.
10
A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women.一项关于雌二醇释放阴道环(Estring)对绝经后妇女复发性尿路感染预防作用的随机、开放、平行组研究。
Am J Obstet Gynecol. 1999 May;180(5):1072-9. doi: 10.1016/s0002-9378(99)70597-1.

引用本文的文献

1
Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial.雌激素和/或益生菌改善加拿大非洲、加勒比和黑人女性阴道健康的可行性、安全性和耐受性:一项1期临床试验试点
PLoS One. 2025 Jan 21;20(1):e0315576. doi: 10.1371/journal.pone.0315576. eCollection 2025.
2
New Possibilities for Hormonal Vaginal Treatment in Menopausal Women.更年期女性激素阴道治疗的新可能性
J Clin Med. 2023 Jul 18;12(14):4740. doi: 10.3390/jcm12144740.
3
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis.
与目前治疗外阴阴道萎缩的疗法相比,奥昔布宁治疗外阴阴道萎缩的疗效、耐受性和子宫内膜安全性:系统文献回顾和网络荟萃分析。
Menopause. 2023 Aug 1;30(8):855-866. doi: 10.1097/GME.0000000000002211. Epub 2023 Jun 27.
4
Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world.阴道环可接受性:来自世界各地的阴道环使用体验的系统评价和荟萃分析。
Contraception. 2022 Feb;106:16-33. doi: 10.1016/j.contraception.2021.10.001. Epub 2021 Oct 10.
5
Development of Hormonal Intravaginal Rings: Technology and Challenges.激素阴道环的研发:技术与挑战
Geburtshilfe Frauenheilkd. 2021 Jul;81(7):789-806. doi: 10.1055/a-1369-9395. Epub 2021 Jul 13.
6
Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.超低剂量 0.005%雌三醇阴道凝胶治疗非甾体芳香化酶抑制剂治疗的早期乳腺癌绝经后妇女外阴阴道萎缩的疗效和安全性:一项 II 期、随机、双盲、安慰剂对照试验。
Menopause. 2020 May;27(5):526-534. doi: 10.1097/GME.0000000000001497.
7
Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review.绝经后妇女使用低剂量阴道雌激素的子宫内膜安全性:系统证据评价。
Menopause. 2019 Jul;26(7):800-807. doi: 10.1097/GME.0000000000001315.
8
User evaluations offer promise for pod-intravaginal ring as a drug delivery platform: A mixed methods study of acceptability and use experiences.用户评估为阴道内环作为药物输送平台提供了前景:一项关于可接受性和使用经验的混合方法研究。
PLoS One. 2018 May 14;13(5):e0197269. doi: 10.1371/journal.pone.0197269. eCollection 2018.
9
Local oestrogen for vaginal atrophy in postmenopausal women.用于绝经后女性阴道萎缩的局部雌激素
Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD001500. doi: 10.1002/14651858.CD001500.pub3.
10
Local Oestrogen for Pelvic Floor Disorders: A Systematic Review.局部雌激素治疗盆底功能障碍:一项系统评价。
PLoS One. 2015 Sep 18;10(9):e0136265. doi: 10.1371/journal.pone.0136265. eCollection 2015.